prediabetes
The partnership will leverage on Holmusk’s GlycoLeap platform to help patients achieve weight loss and improved blood glucose control.
Outcomes from the randomized controlled trial were presented today at a virtual conference. The company and its research partners say this study differs from others due to its size and length.
The company plans to continue to focus on the metabolic health space.
The company will add cognitive behavioral therapy-based coaching via a perpetual licensing agreement with Lantern.
First Mile Care will use demographic data to appropriately match prediabetes patients with coaches and develop more personalized action plans.